227 related articles for article (PubMed ID: 8995504)
1. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.
Olivi A; Ewend MG; Utsuki T; Tyler B; Domb AJ; Brat DJ; Brem H
Cancer Chemother Pharmacol; 1996; 39(1-2):90-6. PubMed ID: 8995504
[TBL] [Abstract][Full Text] [Related]
2. Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.
Pradilla G; Legnani FG; Petrangolini G; Francescato P; Chillemi F; Tyler BM; Gaini SM; Brem H; Olivi A; DiMeco F
Neurosurgery; 2005 Nov; 57(5):1032-40; discussion 1032-40. PubMed ID: 16284573
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
4. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
5. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
[TBL] [Abstract][Full Text] [Related]
6. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT
Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193
[TBL] [Abstract][Full Text] [Related]
7. Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
Legnani FG; Pradilla G; Thai QA; Fiorindi A; Recinos PF; Tyler BM; Gaini SM; DiMeco F; Brem H; Olivi A
J Neurooncol; 2006 May; 77(3):225-32. PubMed ID: 16609837
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.
Degen JW; Walbridge S; Vortmeyer AO; Oldfield EH; Lonser RR
J Neurosurg; 2003 Nov; 99(5):893-8. PubMed ID: 14609170
[TBL] [Abstract][Full Text] [Related]
9. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
10. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
[TBL] [Abstract][Full Text] [Related]
13. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
[TBL] [Abstract][Full Text] [Related]
14. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
[TBL] [Abstract][Full Text] [Related]
15. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
[TBL] [Abstract][Full Text] [Related]
16. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
17. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma.
Hsu W; Lesniak MS; Tyler B; Brem H
J Neurooncol; 2005 Sep; 74(2):135-40. PubMed ID: 16193383
[TBL] [Abstract][Full Text] [Related]
19. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
